The Medical Research Council Clinical Trials Unit (MRC CTU) at UCL is at the forefront of resolving internationally important questions in infectious diseases and cancer, and delivering swifter and more effective translation of scientific research into patient benefits. It does this by carrying out challenging and innovative studies, and developing and implementing methodological advances in study design, conduct and analysis.
We design and conduct innovative and challenging clinical trials. We bring together the results of a number of trials which look at the same illness or condition (this is called a systematic review or meta-analysis). We also undertake observational studies to evaluate the impact of new interventions in routine care.
We are a registered Clinical Trials Unit at the UKCRC Registered CTUs Network.
Our research helps to improve healthcare in the UK and around the world.
Focus on internationally important questions, through challenging and innovative studies, concentrating on infectious diseases and cancer.
We carry out methodological research to help us improve how studies are designed, conducted and analysed. This innovation is inspired by challenges faced by our studies, and helps ensure scientific progress is translated into clinical benefit more rapidly and effectively.
We employ around 250 staff and we are currently co-ordinating around 60 trials and meta-analyses.
Background, publication lists, and contact details for our senior staff.
Learn about the history of the MRC CTU at UCL.
Commitment to the Environment
We are committed to reducing our impact on the environment. Learn more about UCL's commitment to sustainability.
Our Commitment to Equality, Diversity and Inclusion (EDI)
Members of the MRC CTU at UCL serve as co-chairs of the ICTM’s EDI team, a group of staff who work to make the Unit a place where everyone feels valued, and diversity is celebrated.